文献速递腹部CT

克罗恩病患者优化低剂量CT小肠造影方案的前瞻性评估

Prospective evaluation of an optimized low-dose CT enterography protocol for patients with Crohn's disease.
PubMed 文献 · Eur J Radiol · 2026-10-23

前瞻性单中心随机研究纳入102例克罗恩病患者,比较标准剂量、低剂量及低剂量低碘三种CTE方案,主要终点主观图像质量三组无显著差异(p=0.27),优化方案辐射剂量降低约50%,Group C额外降低碘剂量33.3%。

要点

  • 低剂量及低碘CTE方案主观图像质量与标准方案无显著差异(p=0.27)。
  • 优化方案辐射剂量较标准方案降低约50%(Group B 53.2%,Group C 50.0%)。
  • 探索性诊断准确性组间差异置信区间宽,不能解读为诊断等效或非劣。

核心结论

  • 在GE Revolution 256排CT平台上,优化CTE方案降低辐射暴露约50%,Group C额外实现方案定义的碘剂量33.3%降低。
  • 基于剂量和图像质量结果,当辐射降低为主要目标时可合理推荐Group B,当同时希望降低辐射和碘剂量时可考虑Group C。
  • 这些发现未确立图像质量或诊断性能的等效性或非劣性。

研究设计与样本

  • 前瞻性单中心随机研究,纳入102例克罗恩病患者,于2025年2月至10月行CTE。
  • 采用计算机生成随机序列按1:1:1分组,分配隐藏于不透明密封信封中,由不参与患者入组、图像评估或临床数据收集的研究护士打开。
  • 三组方案:标准剂量方案(Group A)、低剂量方案采用100 kVp和70%自适应统计迭代重建-V(ASIR-V)(Group B)、联合低剂量低对比剂方案采用相同采集设置并降低碘剂量(320 mgI/kg,对应1.0 mL/kg对比剂)(Group C)。
  • 主要终点为采用5分Likert量表评估的主观图像质量,次要终点包括客观图像质量、肠壁强化和辐射剂量指标。
  • 诊断性能为探索性分析,仅纳入有合格内镜参考标准的患者,研究未设计也未把握度检验诊断非劣性或等效性。

诊断标准与关键数值

  • 主观图像质量平均评分:Group A 4.3±0.5,Group B 4.5±0.6,Group C 4.5±0.5,组间无显著差异(p=0.27)。
  • Group B vs A差异0.2分(95%CI -0.1至0.5),Group C vs A差异0.2分(95%CI -0.1至0.5),Group C vs B差异0.0分(95%CI -0.3至0.3)。
  • 疾病活动度诊断准确性:Group A 88.0%(95%CI 70.0-95.8%),Group B 89.3%(95%CI 72.8-96.3%),Group C 87.0%(95%CI 67.9-95.5%)。
  • 肠腔狭窄诊断准确性:Group A 84.0%(95%CI 65.3-94.1%),Group B 89.3%(95%CI 72.8-96.3%),Group C 87.0%(95%CI 67.9-95.5%)。

临床应用与阅片要点

  • 当辐射降低为主要目标时可合理推荐Group B(100 kVp、70% ASIR-V),当同时希望降低辐射和碘剂量时可考虑Group C(碘剂量320 mgI/kg)。
  • 本研究未确立图像质量或诊断性能的等效性或非劣性,组间差异置信区间宽且包含可能具有临床意义的值。

局限性

  • 研究未设计也未把握度检验诊断非劣性或等效性。
  • 组间差异的置信区间宽且包含可能具有临床意义的值,缺乏统计学显著差异不应解读为诊断等效或非劣证据。
  • 诊断性能分析为探索性,仅76/102例患者有合格内镜参考标准(Group A 25/31,Group B 28/38,Group C 23/33)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate an optimized CT enterography (CTE) strategy combining reduced radiation exposure and iodine administration in patients with Crohn's disease (CD), with subjective image quality as the primary endpoint.

METHODS: This prospective single-center randomized study enrolled 102 patients with CD who underwent CTE between February and October 2025. Participants were randomly assigned in a 1:1:1 ratio using a computer-generated random sequence, with allocation concealed in sequentially numbered, opaque, sealed envelopes opened by a research nurse not involved in patient enrollment, image evaluation, or clinical data collection. No stratification or blocking was used. The three protocols were: a standard-dose protocol (Group A), a low-dose protocol using 100 kVp and 70% adaptive statistical iterative reconstruction-V (ASIR-V) (Group B), and a combined low-dose, low-contrast protocol using the same acquisition settings with a reduced iodine dose (320 mgI/kg, corresponding to 1.0 mL/kg of contrast medium) (Group C). The primary endpoint was subjective image quality assessed using a 5-point Likert scale. Secondary endpoints included objective image quality, bowel wall enhancement, and radiation dose metrics. Diagnostic performance for disease activity and luminal stenosis was evaluated as an exploratory analysis in patients with an eligible endoscopic reference standard; the study was not designed or powered for diagnostic non-inferiority or equivalence testing.

RESULTS: No statistically significant between-group differences were detected in baseline characteristics (all p > 0.05). For the primary endpoint, mean subjective image quality scores were 4.3 ± 0.5, 4.5 ± 0.6, and 4.5 ± 0.5 in Groups A, B, and C, respectively, with no significant between-group difference (p = 0.27); the between-group differences were 0.2 points (95% CI, -0.1 to 0.5) for Group B versus A, 0.2 points (95% CI, -0.1 to 0.5) for Group C versus A, and 0.0 points (95% CI, -0.3 to 0.3) for Group C versus B. Compared with the standard protocol, the estimated effective radiation dose was reduced by 53.2% in Group B and 50.0% in Group C (both p < 0.001), with no significant difference between the two optimized protocols. Both optimized protocols showed lower image noise and higher signal-to-noise and contrast-to-noise ratios than the standard protocol (all p < 0.05), whereas no statistically significant between-group differences were detected in bowel wall attenuation (all p > 0.05). For the exploratory diagnostic analysis, 76/102 patients had an eligible endoscopic reference standard (Group A, 25/31; Group B, 28/38; Group C, 23/33). Diagnostic accuracy for disease activity was 88.0% (95% CI, 70.0-95.8%) in Group A, 89.3% (95% CI, 72.8-96.3%) in Group B, and 87.0% (95% CI, 67.9-95.5%) in Group C; the corresponding between-group differences were 1.3 percentage points (95% CI, -16.8 to 19.4) for B versus A, -1.0 percentage points (95% CI, -19.4 to 17.4) for C versus A, and 2.3 percentage points (95% CI, -16.6 to 21.2) for B versus C. For luminal stenosis, diagnostic accuracy was 84.0% (95% CI, 65.3-94.1%), 89.3% (95% CI, 72.8-96.3%), and 87.0% (95% CI, 67.9-95.5%), respectively; the absolute differences were 5.3 percentage points (95% CI, -12.1 to 22.7) for B versus A, 3.0 percentage points (95% CI, -15.2 to 21.2) for C versus A, and 2.3 percentage points (95% CI, -16.6 to 21.2) for B versus C. The confidence intervals for between-group differences were wide and included values that could be clinically relevant; because the study was not powered to establish diagnostic non-inferiority or equivalence, the absence of statistically significant differences should not be interpreted as evidence of diagnostic equivalence or non-inferiority.

CONCLUSION: On the GE Revolution 256-detector-row CT platform, the optimized CTE protocols reduced radiation exposure by approximately 50%, while Group C additionally achieved a protocol-defined 33.3% reduction in weight-normalized iodine dose. Based on the observed dose and image-quality findings, Group B can reasonably be recommended when radiation reduction is the primary goal, whereas Group C may be considered when both radiation and iodine reduction are desired. These findings do not establish equivalence or non-inferiority in image quality or diagnostic performance.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Chen H, Tang B, Li J, et al. Prospective evaluation of an optimized low-dose CT enterography protocol for patients with Crohn's disease. Eur J Radiol. 2026. PMID: 42950525. doi:10.1016/j.ejrad.2026.113327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。